Given the proposed role of the SMAD3-PA-I pathway in insulin resistance, these data suggest that deciphering the mechanisms involved in regulation of nuclear GDF15 levels may evolve into a new strategy to prevent the development of insulin resistance and T2DM. Here, SMAD3 is linked to type 2 diabetes mellitus.